NZ HIV Medicine Research Review Issue 50

In this issue:
  -  Novavax SARS-COV-2 vaccine in individuals with or without HIV-1
  -  Cabotegravir for preventing HIV-1 in women
  -  Kidney function in TDF-based oral PrEP users
  -  Interventions to re-engage patients with HIV lost to follow-up
  -  Rising rates of recent PrEP exposure among MSM newly diagnosed with HIV
  -  Evaluation of HIV treatment outcomes with reduced clinical encounters and ART refills
  -  Reasons for PrEP discontinuation
  -  Lung and HPV-associated cancers in HIV
  -  TB screening among HIV-positive inpatients
  -  COVID-19 hospitalisation outcomes in individuals with and without HIV

Please login below to download this issue (PDF)